Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity
about
Erythropoietin in ophthalmology: A literature reviewPharmacologic interventions for the prevention and treatment of retinopathy of prematurityAdenosine receptors and caffeine in retinopathy of prematurity.Endoglin promotes angiogenesis in cell- and animal-based models of retinal neovascularization.Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ.Intravitreal injection of bevacizumab for retinopathy of prematurity.Vascular endothelial growth factor antagonist therapy for retinopathy of prematuritySmouldering retinopathy of prematurity: a case treated by multiple antivascular endothelial growth factor therapy.Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathyShort hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity.Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity.Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity.Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.Pathophysiology and mechanisms of severe retinopathy of prematurity.VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesisAdvances in understanding and management of retinopathy of prematurity.Ocular Adverse Effects of Intravitreal Bevacizumab Are Potentiated by Intermittent Hypoxia in a Rat Model of Oxygen-Induced Retinopathy.Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanisms.Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization.Quantifying three-dimensional rodent retina vascular development using optical tissue clearing and light-sheet microscopy.
P2860
Q26744850-778CDBF6-14E8-4CC8-B927-C33B830F9A45Q26772889-E2EAF3BA-DB06-44F5-BB20-E5A259715DDBQ33860622-A90F4B5D-8D52-48A2-8D7F-CC24044C51FCQ34341837-59917CD8-C663-4407-9998-31C6E51FA678Q34741796-620C5EE8-2411-41CA-B3CB-61E0692AEF75Q35102460-801B4C96-EB82-4D93-B953-56D2582351BCQ35473907-3E9A1DA8-5FDC-4234-BF31-192A87BDE58DQ36116150-8C71C964-7F0B-441C-87A7-33F1353722C0Q36379513-A50FA0DF-4A2C-49BA-9BA6-10F31A80FF9DQ37149035-29B0A112-C4DF-4E92-A220-11CFC6023944Q37561227-4CE360C0-7A27-4084-8B19-C52CB179ABC5Q37577214-4D2E9E6E-B745-4700-91B1-E8F9C673E058Q37623450-50036F09-1C39-4539-A3AE-99522CB9C178Q38274655-2B1E280F-F78D-4BC8-B297-03FC7A8DA03AQ38560836-08C2EF9D-936A-4375-82AF-F41345F903FDQ39052915-4DE44D87-0D19-4A65-A4A5-03B7D5D99FF9Q41100793-4B109AB8-92F1-40C7-9641-02FB05DA10C6Q47828029-13E853F4-50EC-4040-BF0B-17EF599736A3Q48120672-4A5E42FD-C5C2-4E2D-B39C-D58987B72641Q52573106-806F0837-2AC2-4425-8D1D-C538845DB561
P2860
Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Anti-VEGF antibody leads to la ...... of retinopathy of prematurity
@en
type
label
Anti-VEGF antibody leads to la ...... of retinopathy of prematurity
@en
prefLabel
Anti-VEGF antibody leads to la ...... of retinopathy of prematurity
@en
P2093
P2860
P356
P1476
Anti-VEGF antibody leads to la ...... of retinopathy of prematurity
@en
P2093
George Wesley Smith
Haibo Wang
Jeremy Strange
M Elizabeth Hartnett
Manabu McCloskey
Yanchao Jiang
P2860
P304
P356
10.1167/IOVS.13-11625
P407
P577
2013-03-21T00:00:00Z